NPCE
NeuroPace, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$14.90
+1.02%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 43.04x
- Price / sales
- 5.17x
- Price / cash flow
- -45.50x
Enterprise value
- Enterprise value
- $529.7M
- EV / sales
- 5.36x
- EV / EBITDA
- -43.11x
- EV / EBIT
- -35.13x
- Market cap
- $511.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026